| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |